OptimizeRx Corp. announced a new artificial intelligence (AI) solution, transforming its HCP engagement platform. The new capability expands the Company's patent-pending HCP engagement technology to include social, web-display channels, and CRM alerts, which create more efficiencies directly with sales forces.

With this development, the Company has renamed its HCP engagement platform the Dynamic Audience Activation Platform (DAAP), to mark the unification of its former RWD-AI capability with its full omni-channel network and new proprietary physician engagement dataset. The new DAAP advances the Company's land-and-expand strategy by enabling its clients to gain maximum market penetration by scaling their outreach in real-time across the Company's network of over 2 million HCPs across multiple major digital media channels, and at point-of-care via electronic health records (EHR), e-Prescribing, and telehealth platforms. The next-generation AI-guided DAAP selectively activates HCP audiences for messaging across channels based on patient care windows, driving more value for life sciences customers by improving the impact of their marketing efforts. In a recent pilot program, the Company reported a 19% script lift among AI-identified HCPs seeing relevant patients, including early impact among audience cohorts who had historically high script writing behaviors.